MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice

Federica Sala, Juan F. Aranda, Noemi Rotllan, Cristina M. Ramírez, Binod Aryal, Leonardo Elia, Gianluigi Condorelli, Alberico Luigi Catapano, Carlos Fernández-Hernando, Giuseppe Danilo Norata

Research output: Contribution to journalArticle

Abstract

The miR-143/145 cluster regulates VSMC specific gene expression, thus controlling differentiation, plasticity and contractile function, and promoting the VSMC phenotypic switch from a contractile/non-proliferative to a migrating/proliferative state. More recently increased miR-145 expression was observed in human carotid atherosclerotic plaques from symptomatic patients. The goal of this study was to investigate the contribution of miR-143/145 during atherogenesis by generating mice lacking miR-143/145 on an Ldlr-deficient background. Ldlr-/- and Ldlr-/--miR-143/145-/- (DKO) were fed a Western diet (WD) for 16 weeks. At the end of the treatment, the lipid profile and the atherosclerotic lesions were assessed in both groups of mice. Absence of miR-143/145 significantly reduced atherosclerotic plaque size and macrophage infiltration. Plasma total cholesterol levels were lower in DKO and FLPC analysis showed decreased cholesterol content in VLDL and LDL fractions. Interestingly miR-143/145 deficiency per se resulted in increased hepatic and vascular ABCA1 expression. We further confirmed the direct regulation of miR-145 on ABCA1 expression by qRT-PCR, Western blotting and 3’UTR-luciferase reporter assays. In summary, miR-143/145 deficiency significantly reduces atherosclerosis in mice. Therapeutic inhibition of miR-145 might be useful for treating atherosclerotic vascular disease.

Original languageEnglish
Pages (from-to)796-802
Number of pages7
JournalThrombosis and Haemostasis
Volume112
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Atherosclerosis
Atherosclerotic Plaques
Cholesterol
Luciferases
Vascular Diseases
Blood Vessels
Western Blotting
Macrophages
Lipids
Gene Expression
Polymerase Chain Reaction
Liver
Therapeutics
Western Diet
low density lipoprotein inhibitor

Keywords

  • ABCA1
  • Atherosclerosis
  • MiR-143/145
  • Smooth muscle cells

ASJC Scopus subject areas

  • Hematology
  • Medicine(all)

Cite this

Sala, F., Aranda, J. F., Rotllan, N., Ramírez, C. M., Aryal, B., Elia, L., ... Norata, G. D. (2014). MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice. Thrombosis and Haemostasis, 112(4), 796-802. https://doi.org/10.1160/TH13-11-0905

MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice. / Sala, Federica; Aranda, Juan F.; Rotllan, Noemi; Ramírez, Cristina M.; Aryal, Binod; Elia, Leonardo; Condorelli, Gianluigi; Catapano, Alberico Luigi; Fernández-Hernando, Carlos; Norata, Giuseppe Danilo.

In: Thrombosis and Haemostasis, Vol. 112, No. 4, 2014, p. 796-802.

Research output: Contribution to journalArticle

Sala, F, Aranda, JF, Rotllan, N, Ramírez, CM, Aryal, B, Elia, L, Condorelli, G, Catapano, AL, Fernández-Hernando, C & Norata, GD 2014, 'MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice', Thrombosis and Haemostasis, vol. 112, no. 4, pp. 796-802. https://doi.org/10.1160/TH13-11-0905
Sala, Federica ; Aranda, Juan F. ; Rotllan, Noemi ; Ramírez, Cristina M. ; Aryal, Binod ; Elia, Leonardo ; Condorelli, Gianluigi ; Catapano, Alberico Luigi ; Fernández-Hernando, Carlos ; Norata, Giuseppe Danilo. / MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice. In: Thrombosis and Haemostasis. 2014 ; Vol. 112, No. 4. pp. 796-802.
@article{7444e9c3f8ba4091a8ef478c1d5b3ad5,
title = "MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice",
abstract = "The miR-143/145 cluster regulates VSMC specific gene expression, thus controlling differentiation, plasticity and contractile function, and promoting the VSMC phenotypic switch from a contractile/non-proliferative to a migrating/proliferative state. More recently increased miR-145 expression was observed in human carotid atherosclerotic plaques from symptomatic patients. The goal of this study was to investigate the contribution of miR-143/145 during atherogenesis by generating mice lacking miR-143/145 on an Ldlr-deficient background. Ldlr-/- and Ldlr-/--miR-143/145-/- (DKO) were fed a Western diet (WD) for 16 weeks. At the end of the treatment, the lipid profile and the atherosclerotic lesions were assessed in both groups of mice. Absence of miR-143/145 significantly reduced atherosclerotic plaque size and macrophage infiltration. Plasma total cholesterol levels were lower in DKO and FLPC analysis showed decreased cholesterol content in VLDL and LDL fractions. Interestingly miR-143/145 deficiency per se resulted in increased hepatic and vascular ABCA1 expression. We further confirmed the direct regulation of miR-145 on ABCA1 expression by qRT-PCR, Western blotting and 3’UTR-luciferase reporter assays. In summary, miR-143/145 deficiency significantly reduces atherosclerosis in mice. Therapeutic inhibition of miR-145 might be useful for treating atherosclerotic vascular disease.",
keywords = "ABCA1, Atherosclerosis, MiR-143/145, Smooth muscle cells",
author = "Federica Sala and Aranda, {Juan F.} and Noemi Rotllan and Ram{\'i}rez, {Cristina M.} and Binod Aryal and Leonardo Elia and Gianluigi Condorelli and Catapano, {Alberico Luigi} and Carlos Fern{\'a}ndez-Hernando and Norata, {Giuseppe Danilo}",
year = "2014",
doi = "10.1160/TH13-11-0905",
language = "English",
volume = "112",
pages = "796--802",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "4",

}

TY - JOUR

T1 - MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice

AU - Sala, Federica

AU - Aranda, Juan F.

AU - Rotllan, Noemi

AU - Ramírez, Cristina M.

AU - Aryal, Binod

AU - Elia, Leonardo

AU - Condorelli, Gianluigi

AU - Catapano, Alberico Luigi

AU - Fernández-Hernando, Carlos

AU - Norata, Giuseppe Danilo

PY - 2014

Y1 - 2014

N2 - The miR-143/145 cluster regulates VSMC specific gene expression, thus controlling differentiation, plasticity and contractile function, and promoting the VSMC phenotypic switch from a contractile/non-proliferative to a migrating/proliferative state. More recently increased miR-145 expression was observed in human carotid atherosclerotic plaques from symptomatic patients. The goal of this study was to investigate the contribution of miR-143/145 during atherogenesis by generating mice lacking miR-143/145 on an Ldlr-deficient background. Ldlr-/- and Ldlr-/--miR-143/145-/- (DKO) were fed a Western diet (WD) for 16 weeks. At the end of the treatment, the lipid profile and the atherosclerotic lesions were assessed in both groups of mice. Absence of miR-143/145 significantly reduced atherosclerotic plaque size and macrophage infiltration. Plasma total cholesterol levels were lower in DKO and FLPC analysis showed decreased cholesterol content in VLDL and LDL fractions. Interestingly miR-143/145 deficiency per se resulted in increased hepatic and vascular ABCA1 expression. We further confirmed the direct regulation of miR-145 on ABCA1 expression by qRT-PCR, Western blotting and 3’UTR-luciferase reporter assays. In summary, miR-143/145 deficiency significantly reduces atherosclerosis in mice. Therapeutic inhibition of miR-145 might be useful for treating atherosclerotic vascular disease.

AB - The miR-143/145 cluster regulates VSMC specific gene expression, thus controlling differentiation, plasticity and contractile function, and promoting the VSMC phenotypic switch from a contractile/non-proliferative to a migrating/proliferative state. More recently increased miR-145 expression was observed in human carotid atherosclerotic plaques from symptomatic patients. The goal of this study was to investigate the contribution of miR-143/145 during atherogenesis by generating mice lacking miR-143/145 on an Ldlr-deficient background. Ldlr-/- and Ldlr-/--miR-143/145-/- (DKO) were fed a Western diet (WD) for 16 weeks. At the end of the treatment, the lipid profile and the atherosclerotic lesions were assessed in both groups of mice. Absence of miR-143/145 significantly reduced atherosclerotic plaque size and macrophage infiltration. Plasma total cholesterol levels were lower in DKO and FLPC analysis showed decreased cholesterol content in VLDL and LDL fractions. Interestingly miR-143/145 deficiency per se resulted in increased hepatic and vascular ABCA1 expression. We further confirmed the direct regulation of miR-145 on ABCA1 expression by qRT-PCR, Western blotting and 3’UTR-luciferase reporter assays. In summary, miR-143/145 deficiency significantly reduces atherosclerosis in mice. Therapeutic inhibition of miR-145 might be useful for treating atherosclerotic vascular disease.

KW - ABCA1

KW - Atherosclerosis

KW - MiR-143/145

KW - Smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=84908519519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908519519&partnerID=8YFLogxK

U2 - 10.1160/TH13-11-0905

DO - 10.1160/TH13-11-0905

M3 - Article

C2 - 25008143

AN - SCOPUS:84908519519

VL - 112

SP - 796

EP - 802

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 4

ER -